Sean O'Leary
Concepts (412)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccination | 108 | 2024 | 1222 | 18.460 |
Why?
| Vaccines | 37 | 2024 | 380 | 11.170 |
Why?
| Papillomavirus Vaccines | 32 | 2024 | 221 | 8.240 |
Why?
| Influenza Vaccines | 37 | 2023 | 500 | 6.750 |
Why?
| Health Knowledge, Attitudes, Practice | 37 | 2023 | 1185 | 6.160 |
Why?
| Immunization | 25 | 2024 | 412 | 5.690 |
Why?
| Parents | 33 | 2023 | 1212 | 5.140 |
Why?
| Vaccination Refusal | 14 | 2022 | 69 | 5.060 |
Why?
| Immunization Programs | 13 | 2021 | 206 | 4.940 |
Why?
| Obstetrics | 14 | 2022 | 162 | 4.900 |
Why?
| Gynecology | 13 | 2022 | 184 | 4.440 |
Why?
| Motivational Interviewing | 10 | 2023 | 84 | 4.370 |
Why?
| Papillomavirus Infections | 19 | 2024 | 265 | 4.320 |
Why?
| Patient Acceptance of Health Care | 24 | 2022 | 687 | 4.040 |
Why?
| Influenza, Human | 21 | 2024 | 554 | 3.840 |
Why?
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 12 | 2022 | 89 | 3.590 |
Why?
| Practice Patterns, Physicians' | 24 | 2021 | 1200 | 3.420 |
Why?
| Immunization Schedule | 20 | 2023 | 188 | 3.320 |
Why?
| Attitude of Health Personnel | 26 | 2021 | 992 | 3.290 |
Why?
| Pregnancy Complications, Infectious | 8 | 2023 | 296 | 3.190 |
Why?
| Clergy | 4 | 2020 | 13 | 2.860 |
Why?
| Hepatitis B | 4 | 2023 | 52 | 2.410 |
Why?
| Advisory Committees | 15 | 2024 | 212 | 2.320 |
Why?
| Meningococcal Vaccines | 10 | 2024 | 49 | 2.240 |
Why?
| Pediatrics | 16 | 2021 | 985 | 2.200 |
Why?
| Religion | 3 | 2020 | 68 | 2.090 |
Why?
| Health Communication | 4 | 2021 | 44 | 2.090 |
Why?
| Colorado | 34 | 2024 | 4196 | 2.090 |
Why?
| Health Personnel | 12 | 2022 | 588 | 2.010 |
Why?
| Vaccination Coverage | 8 | 2024 | 63 | 2.010 |
Why?
| Humans | 180 | 2024 | 118972 | 1.990 |
Why?
| Whooping Cough | 6 | 2022 | 49 | 1.970 |
Why?
| Child | 63 | 2024 | 19129 | 1.960 |
Why?
| Physicians, Primary Care | 11 | 2021 | 222 | 1.930 |
Why?
| Viral Vaccines | 3 | 2020 | 90 | 1.890 |
Why?
| Attitude to Health | 9 | 2020 | 410 | 1.890 |
Why?
| Pediatricians | 8 | 2022 | 120 | 1.860 |
Why?
| Pregnancy | 34 | 2024 | 5690 | 1.720 |
Why?
| United States | 49 | 2023 | 12555 | 1.610 |
Why?
| Infant | 40 | 2024 | 8293 | 1.590 |
Why?
| Female | 107 | 2024 | 61564 | 1.570 |
Why?
| Social Media | 4 | 2021 | 133 | 1.510 |
Why?
| Communication | 11 | 2023 | 761 | 1.500 |
Why?
| Pregnant Women | 8 | 2022 | 132 | 1.480 |
Why?
| Treatment Refusal | 5 | 2020 | 86 | 1.450 |
Why?
| Primary Health Care | 13 | 2021 | 1560 | 1.330 |
Why?
| Health Promotion | 5 | 2020 | 691 | 1.320 |
Why?
| Adult | 62 | 2022 | 31512 | 1.310 |
Why?
| Adolescent | 49 | 2024 | 18480 | 1.310 |
Why?
| Adolescent Health Services | 4 | 2015 | 67 | 1.290 |
Why?
| Physicians, Family | 10 | 2021 | 206 | 1.270 |
Why?
| Surveys and Questionnaires | 32 | 2024 | 4708 | 1.250 |
Why?
| Measles | 4 | 2022 | 39 | 1.140 |
Why?
| Prenatal Care | 2 | 2020 | 252 | 1.130 |
Why?
| Physicians | 11 | 2022 | 794 | 1.100 |
Why?
| Infectious Disease Transmission, Vertical | 4 | 2023 | 156 | 1.090 |
Why?
| Diphtheria | 4 | 2022 | 20 | 1.070 |
Why?
| Measles-Mumps-Rubella Vaccine | 3 | 2022 | 41 | 1.070 |
Why?
| Tetanus | 4 | 2022 | 25 | 1.070 |
Why?
| Patient Outcome Assessment | 2 | 2019 | 122 | 1.060 |
Why?
| Policy | 3 | 2020 | 133 | 1.010 |
Why?
| Health Care Surveys | 12 | 2021 | 546 | 1.000 |
Why?
| Child, Preschool | 25 | 2023 | 9491 | 0.960 |
Why?
| Practice Guidelines as Topic | 11 | 2023 | 1440 | 0.940 |
Why?
| Male | 71 | 2024 | 57801 | 0.940 |
Why?
| Ambulatory Care | 4 | 2020 | 482 | 0.930 |
Why?
| Physician-Patient Relations | 5 | 2020 | 490 | 0.890 |
Why?
| Religion and Medicine | 2 | 2019 | 28 | 0.880 |
Why?
| Pandemics | 5 | 2024 | 1355 | 0.870 |
Why?
| Reminder Systems | 4 | 2019 | 163 | 0.860 |
Why?
| Anterior Cruciate Ligament Reconstruction | 4 | 2022 | 143 | 0.830 |
Why?
| Hepatitis B Vaccines | 4 | 2023 | 46 | 0.820 |
Why?
| Trust | 2 | 2020 | 113 | 0.810 |
Why?
| Refusal to Treat | 2 | 2020 | 19 | 0.810 |
Why?
| Arthritis, Infectious | 1 | 2022 | 52 | 0.810 |
Why?
| Health Services Research | 4 | 2019 | 385 | 0.800 |
Why?
| Herpes Zoster Vaccine | 6 | 2022 | 159 | 0.780 |
Why?
| Private Practice | 1 | 2020 | 21 | 0.780 |
Why?
| Infant, Newborn | 14 | 2023 | 5255 | 0.770 |
Why?
| Standing Orders | 2 | 2020 | 11 | 0.770 |
Why?
| Preventive Health Services | 2 | 2020 | 135 | 0.760 |
Why?
| Professional-Patient Relations | 3 | 2018 | 147 | 0.760 |
Why?
| Pneumococcal Vaccines | 6 | 2021 | 140 | 0.750 |
Why?
| Osteomyelitis | 1 | 2022 | 110 | 0.750 |
Why?
| Middle Aged | 37 | 2021 | 27617 | 0.730 |
Why?
| Myocarditis | 1 | 2021 | 95 | 0.730 |
Why?
| Anti-Vaccination Movement | 1 | 2019 | 4 | 0.730 |
Why?
| Stakeholder Participation | 1 | 2020 | 69 | 0.730 |
Why?
| Cross-Sectional Studies | 11 | 2022 | 4552 | 0.720 |
Why?
| Text Messaging | 3 | 2019 | 155 | 0.720 |
Why?
| Community Participation | 1 | 2020 | 120 | 0.720 |
Why?
| Down Syndrome | 2 | 2021 | 356 | 0.710 |
Why?
| Freedom | 1 | 2019 | 12 | 0.710 |
Why?
| Health Care Costs | 3 | 2020 | 394 | 0.710 |
Why?
| Safety-net Providers | 1 | 2021 | 96 | 0.710 |
Why?
| Young Adult | 21 | 2024 | 10793 | 0.700 |
Why?
| Schools | 2 | 2019 | 411 | 0.690 |
Why?
| Disease Outbreaks | 3 | 2022 | 322 | 0.690 |
Why?
| Chickenpox Vaccine | 3 | 2017 | 69 | 0.680 |
Why?
| Public Health | 3 | 2024 | 450 | 0.660 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 140 | 0.660 |
Why?
| Information Seeking Behavior | 1 | 2018 | 36 | 0.640 |
Why?
| Rotavirus Vaccines | 2 | 2021 | 48 | 0.640 |
Why?
| Mothers | 5 | 2022 | 682 | 0.630 |
Why?
| Rotavirus Infections | 2 | 2021 | 54 | 0.630 |
Why?
| Patient Preference | 2 | 2017 | 170 | 0.630 |
Why?
| Documentation | 2 | 2019 | 175 | 0.630 |
Why?
| Rural Population | 4 | 2021 | 452 | 0.620 |
Why?
| Urban Population | 3 | 2020 | 409 | 0.620 |
Why?
| Hepatitis A Vaccines | 4 | 2019 | 15 | 0.610 |
Why?
| Cues | 1 | 2019 | 297 | 0.600 |
Why?
| Mass Media | 1 | 2016 | 38 | 0.570 |
Why?
| Health Education | 2 | 2018 | 318 | 0.570 |
Why?
| Physician's Role | 2 | 2019 | 200 | 0.570 |
Why?
| Mumps | 3 | 2022 | 24 | 0.560 |
Why?
| School Health Services | 3 | 2015 | 203 | 0.550 |
Why?
| Delivery of Health Care | 3 | 2023 | 867 | 0.540 |
Why?
| Vaccines, Combined | 4 | 2023 | 46 | 0.530 |
Why?
| Healthcare Disparities | 1 | 2021 | 496 | 0.520 |
Why?
| Computers, Handheld | 1 | 2015 | 25 | 0.520 |
Why?
| Uterine Cervical Neoplasms | 1 | 2018 | 216 | 0.520 |
Why?
| Dengue Vaccines | 3 | 2019 | 9 | 0.500 |
Why?
| Anthrax Vaccines | 3 | 2018 | 7 | 0.500 |
Why?
| Streptococcal Vaccines | 1 | 2014 | 7 | 0.490 |
Why?
| Hepatitis B Surface Antigens | 2 | 2023 | 19 | 0.470 |
Why?
| Recovery of Function | 2 | 2020 | 604 | 0.470 |
Why?
| Internet | 5 | 2019 | 633 | 0.460 |
Why?
| Qualitative Research | 6 | 2020 | 953 | 0.440 |
Why?
| Seizures, Febrile | 1 | 2012 | 19 | 0.440 |
Why?
| Patient-Centered Care | 2 | 2015 | 497 | 0.440 |
Why?
| Meningococcal Infections | 3 | 2018 | 20 | 0.430 |
Why?
| Respiratory Syncytial Virus Vaccines | 3 | 2023 | 24 | 0.430 |
Why?
| Safety | 2 | 2020 | 304 | 0.430 |
Why?
| Nurseries, Hospital | 1 | 2012 | 4 | 0.420 |
Why?
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 15 | 0.420 |
Why?
| Georgia | 6 | 2021 | 61 | 0.420 |
Why?
| Streptococcal Infections | 1 | 2014 | 141 | 0.410 |
Why?
| Herpes Zoster | 3 | 2022 | 336 | 0.410 |
Why?
| Age Factors | 6 | 2021 | 2995 | 0.410 |
Why?
| Family Practice | 7 | 2017 | 438 | 0.390 |
Why?
| Skin Diseases, Bacterial | 3 | 2016 | 24 | 0.390 |
Why?
| Rotator Cuff | 3 | 2009 | 52 | 0.380 |
Why?
| Mumps Vaccine | 3 | 2021 | 13 | 0.380 |
Why?
| Pertussis Vaccine | 3 | 2022 | 21 | 0.380 |
Why?
| Evidence-Based Medicine | 4 | 2020 | 693 | 0.370 |
Why?
| Respiratory Syncytial Virus Infections | 2 | 2023 | 99 | 0.360 |
Why?
| Attitude | 3 | 2021 | 231 | 0.360 |
Why?
| Respiratory Syncytial Viruses | 3 | 2024 | 48 | 0.350 |
Why?
| Tenodesis | 1 | 2009 | 22 | 0.350 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2020 | 1244 | 0.350 |
Why?
| Neisseria meningitidis | 2 | 2024 | 19 | 0.350 |
Why?
| Anterior Cruciate Ligament Injuries | 2 | 2022 | 147 | 0.340 |
Why?
| Japanese Encephalitis Vaccines | 2 | 2018 | 2 | 0.340 |
Why?
| Vaccines, Contraceptive | 1 | 2008 | 1 | 0.340 |
Why?
| Egg Proteins | 1 | 2008 | 19 | 0.330 |
Why?
| Health Policy | 1 | 2012 | 333 | 0.330 |
Why?
| Hepatitis B virus | 2 | 2023 | 25 | 0.330 |
Why?
| Aged | 16 | 2021 | 19657 | 0.330 |
Why?
| Ovulation | 1 | 2008 | 41 | 0.330 |
Why?
| Tendon Injuries | 1 | 2009 | 80 | 0.330 |
Why?
| Retrospective Studies | 12 | 2023 | 12978 | 0.320 |
Why?
| Ovarian Follicle | 1 | 2008 | 61 | 0.320 |
Why?
| Guideline Adherence | 2 | 2013 | 523 | 0.320 |
Why?
| Societies, Medical | 4 | 2019 | 703 | 0.310 |
Why?
| Cytomegalovirus | 1 | 2008 | 144 | 0.310 |
Why?
| Mobile Applications | 2 | 2020 | 147 | 0.300 |
Why?
| Maternal Health Services | 2 | 2019 | 83 | 0.300 |
Why?
| Child Health | 2 | 2019 | 137 | 0.300 |
Why?
| Professional-Family Relations | 3 | 2018 | 133 | 0.300 |
Why?
| Vaccines, Synthetic | 3 | 2022 | 128 | 0.290 |
Why?
| Logistic Models | 3 | 2021 | 1901 | 0.280 |
Why?
| Cost-Benefit Analysis | 2 | 2020 | 554 | 0.280 |
Why?
| Receptors, Cell Surface | 1 | 2008 | 367 | 0.280 |
Why?
| Membrane Glycoproteins | 1 | 2008 | 446 | 0.280 |
Why?
| Data Collection | 3 | 2014 | 658 | 0.270 |
Why?
| Shoulder Joint | 2 | 2008 | 174 | 0.260 |
Why?
| Time Factors | 4 | 2020 | 6412 | 0.250 |
Why?
| Seasons | 2 | 2020 | 461 | 0.240 |
Why?
| Patient Education as Topic | 2 | 2019 | 699 | 0.240 |
Why?
| Blood Coagulation Tests | 1 | 2023 | 58 | 0.240 |
Why?
| Decision Making | 3 | 2020 | 809 | 0.230 |
Why?
| Hospitals | 3 | 2023 | 598 | 0.220 |
Why?
| Gout | 1 | 2003 | 57 | 0.210 |
Why?
| Rubella | 1 | 2022 | 22 | 0.210 |
Why?
| Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.210 |
Why?
| Intention | 2 | 2020 | 142 | 0.210 |
Why?
| Infant Health | 1 | 2022 | 21 | 0.210 |
Why?
| Hospitalization | 7 | 2023 | 1785 | 0.210 |
Why?
| Russia | 1 | 2021 | 9 | 0.200 |
Why?
| Complementary Therapies | 1 | 2022 | 71 | 0.200 |
Why?
| Germany | 1 | 2021 | 89 | 0.200 |
Why?
| Anti-Bacterial Agents | 3 | 2016 | 1510 | 0.200 |
Why?
| Yellow Fever Vaccine | 2 | 2017 | 6 | 0.200 |
Why?
| Knee Injuries | 1 | 2022 | 103 | 0.200 |
Why?
| Hospital Rapid Response Team | 1 | 2021 | 15 | 0.200 |
Why?
| General Practitioners | 1 | 2021 | 22 | 0.200 |
Why?
| Risk | 2 | 2015 | 853 | 0.190 |
Why?
| Demography | 2 | 2024 | 274 | 0.190 |
Why?
| Clinical Competence | 2 | 2018 | 951 | 0.190 |
Why?
| Internal Medicine | 2 | 2014 | 215 | 0.190 |
Why?
| Regression Analysis | 2 | 2020 | 983 | 0.190 |
Why?
| Antiviral Agents | 2 | 2023 | 654 | 0.190 |
Why?
| Cluster Analysis | 2 | 2022 | 481 | 0.190 |
Why?
| Aged, 80 and over | 5 | 2020 | 6561 | 0.190 |
Why?
| Measles Vaccine | 1 | 2019 | 17 | 0.180 |
Why?
| Washington | 1 | 2020 | 141 | 0.180 |
Why?
| Drug Storage | 1 | 2020 | 59 | 0.180 |
Why?
| Norovirus | 1 | 2020 | 23 | 0.180 |
Why?
| Fever | 1 | 2021 | 283 | 0.180 |
Why?
| Eligibility Determination | 1 | 2020 | 55 | 0.180 |
Why?
| Personnel Staffing and Scheduling | 1 | 2020 | 81 | 0.180 |
Why?
| Pennsylvania | 1 | 2019 | 101 | 0.180 |
Why?
| Reimbursement Mechanisms | 1 | 2020 | 79 | 0.180 |
Why?
| State Government | 1 | 2019 | 41 | 0.180 |
Why?
| Motivation | 1 | 2024 | 506 | 0.180 |
Why?
| Government Regulation | 1 | 2019 | 47 | 0.180 |
Why?
| Medicaid | 2 | 2021 | 411 | 0.170 |
Why?
| Insurance, Health, Reimbursement | 2 | 2017 | 88 | 0.170 |
Why?
| Gastroenteritis | 1 | 2020 | 64 | 0.170 |
Why?
| Europe | 1 | 2020 | 356 | 0.170 |
Why?
| Therapeutic Uses | 1 | 2018 | 1 | 0.170 |
Why?
| Morbidity | 1 | 2020 | 296 | 0.170 |
Why?
| Pulmonary Alveoli | 1 | 2021 | 384 | 0.160 |
Why?
| Community-Based Participatory Research | 1 | 2019 | 133 | 0.160 |
Why?
| Urban Health Services | 1 | 2018 | 60 | 0.160 |
Why?
| Education, Continuing | 1 | 2018 | 40 | 0.160 |
Why?
| Quality Improvement | 3 | 2020 | 963 | 0.160 |
Why?
| Evidence-Based Practice | 2 | 2020 | 193 | 0.160 |
Why?
| Nuclear Family | 1 | 2018 | 54 | 0.160 |
Why?
| Rural Health Services | 1 | 2018 | 93 | 0.160 |
Why?
| Ambulatory Care Facilities | 2 | 2019 | 218 | 0.160 |
Why?
| Guatemala | 4 | 2020 | 296 | 0.150 |
Why?
| Altitude | 1 | 2021 | 422 | 0.150 |
Why?
| Cervical Plexus | 1 | 1997 | 1 | 0.150 |
Why?
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 69 | 0.150 |
Why?
| Hemorrhage | 1 | 2021 | 623 | 0.150 |
Why?
| Spinal Nerve Roots | 1 | 1997 | 30 | 0.150 |
Why?
| Travel | 1 | 2017 | 116 | 0.150 |
Why?
| Adaptation, Psychological | 2 | 2020 | 557 | 0.150 |
Why?
| Pneumococcal Infections | 1 | 2018 | 96 | 0.150 |
Why?
| Administrative Personnel | 1 | 2016 | 33 | 0.140 |
Why?
| Cost of Illness | 2 | 2018 | 258 | 0.140 |
Why?
| Behavior Therapy | 1 | 2019 | 237 | 0.140 |
Why?
| Focus Groups | 5 | 2018 | 387 | 0.140 |
Why?
| Multivariate Analysis | 1 | 2020 | 1474 | 0.140 |
Why?
| Allied Health Personnel | 1 | 2016 | 44 | 0.140 |
Why?
| Physician Executives | 1 | 2016 | 37 | 0.140 |
Why?
| Mass Screening | 1 | 2023 | 1052 | 0.140 |
Why?
| Vaccines, Conjugate | 2 | 2018 | 63 | 0.140 |
Why?
| Curriculum | 1 | 2023 | 910 | 0.140 |
Why?
| Leadership | 1 | 2019 | 311 | 0.140 |
Why?
| Public Health Practice | 1 | 2016 | 62 | 0.140 |
Why?
| Zika Virus Infection | 1 | 2017 | 85 | 0.140 |
Why?
| Diphtheria Toxoid | 1 | 2015 | 12 | 0.140 |
Why?
| Postpartum Period | 1 | 2018 | 271 | 0.140 |
Why?
| Incidence | 2 | 2020 | 2424 | 0.140 |
Why?
| Minority Groups | 1 | 2018 | 237 | 0.140 |
Why?
| Tetanus Toxoid | 1 | 2015 | 37 | 0.140 |
Why?
| Patient Participation | 1 | 2019 | 369 | 0.140 |
Why?
| Intention to Treat Analysis | 1 | 2015 | 70 | 0.140 |
Why?
| Equipment and Supplies | 1 | 2015 | 39 | 0.130 |
Why?
| Cooperative Behavior | 3 | 2014 | 408 | 0.130 |
Why?
| Pre-Exposure Prophylaxis | 1 | 2017 | 174 | 0.130 |
Why?
| Herpesvirus 3, Human | 1 | 2019 | 389 | 0.130 |
Why?
| Information Dissemination | 1 | 2017 | 210 | 0.130 |
Why?
| California | 1 | 2016 | 382 | 0.130 |
Why?
| Prevalence | 1 | 2021 | 2326 | 0.130 |
Why?
| Neck Pain | 1 | 2014 | 24 | 0.130 |
Why?
| Occupational Health Services | 1 | 2014 | 31 | 0.130 |
Why?
| Lung Diseases | 1 | 2021 | 718 | 0.130 |
Why?
| Anterior Cruciate Ligament | 1 | 2015 | 89 | 0.120 |
Why?
| Prospective Studies | 3 | 2021 | 6471 | 0.120 |
Why?
| Nurses | 1 | 2016 | 142 | 0.120 |
Why?
| Poverty | 1 | 2018 | 444 | 0.120 |
Why?
| Sexual Behavior | 1 | 2018 | 437 | 0.120 |
Why?
| Public Health Administration | 1 | 2014 | 78 | 0.120 |
Why?
| Clinical Decision-Making | 3 | 2021 | 278 | 0.110 |
Why?
| Circovirus | 1 | 2013 | 7 | 0.110 |
Why?
| Adolescent Behavior | 1 | 2018 | 482 | 0.110 |
Why?
| Intussusception | 1 | 2013 | 27 | 0.110 |
Why?
| Social Behavior | 1 | 2015 | 276 | 0.110 |
Why?
| Parent-Child Relations | 1 | 2015 | 232 | 0.110 |
Why?
| Drug Contamination | 1 | 2013 | 54 | 0.110 |
Why?
| Workplace | 1 | 2014 | 222 | 0.110 |
Why?
| Health Services Accessibility | 1 | 2019 | 781 | 0.110 |
Why?
| Product Surveillance, Postmarketing | 1 | 2013 | 64 | 0.110 |
Why?
| Follow-Up Studies | 3 | 2020 | 4596 | 0.110 |
Why?
| Electronic Health Records | 1 | 2019 | 829 | 0.110 |
Why?
| Patient Compliance | 1 | 2016 | 537 | 0.100 |
Why?
| Outpatients | 1 | 2015 | 325 | 0.100 |
Why?
| Professional Practice Location | 1 | 2011 | 26 | 0.100 |
Why?
| Perinatal Care | 1 | 2012 | 37 | 0.100 |
Why?
| Community-Institutional Relations | 1 | 2012 | 91 | 0.100 |
Why?
| Risk Factors | 4 | 2023 | 9000 | 0.100 |
Why?
| United Kingdom | 3 | 2020 | 236 | 0.100 |
Why?
| Pneumonia, Pneumococcal | 1 | 2010 | 40 | 0.090 |
Why?
| Cognition | 1 | 2018 | 1024 | 0.090 |
Why?
| Swine | 1 | 2013 | 730 | 0.090 |
Why?
| Pain Measurement | 1 | 2012 | 469 | 0.090 |
Why?
| Sports | 1 | 2012 | 194 | 0.090 |
Why?
| Hospices | 1 | 2011 | 79 | 0.090 |
Why?
| Activities of Daily Living | 1 | 2012 | 354 | 0.090 |
Why?
| Neuromuscular Diseases | 1 | 2011 | 90 | 0.090 |
Why?
| Communicable Diseases | 2 | 2022 | 132 | 0.090 |
Why?
| Rotator Cuff Injuries | 1 | 2009 | 61 | 0.090 |
Why?
| Zona Pellucida Glycoproteins | 1 | 2008 | 2 | 0.080 |
Why?
| Growth Differentiation Factor 9 | 1 | 2008 | 4 | 0.080 |
Why?
| Connexin 43 | 1 | 2008 | 23 | 0.080 |
Why?
| Infertility, Female | 1 | 2008 | 94 | 0.080 |
Why?
| Embryonic Development | 1 | 2008 | 118 | 0.080 |
Why?
| Appointments and Schedules | 2 | 2019 | 78 | 0.080 |
Why?
| Registries | 1 | 2015 | 1810 | 0.080 |
Why?
| Leukocytes | 1 | 2008 | 290 | 0.070 |
Why?
| Cell Phone | 2 | 2019 | 81 | 0.070 |
Why?
| Ovary | 1 | 2008 | 205 | 0.070 |
Why?
| Quality of Life | 2 | 2020 | 2366 | 0.070 |
Why?
| Tendons | 1 | 2008 | 137 | 0.070 |
Why?
| Health Surveys | 2 | 2018 | 454 | 0.070 |
Why?
| Fetal Development | 1 | 2008 | 250 | 0.070 |
Why?
| Mice, Inbred BALB C | 1 | 2008 | 1206 | 0.070 |
Why?
| Cohort Studies | 2 | 2014 | 5116 | 0.070 |
Why?
| Homeodomain Proteins | 1 | 2008 | 468 | 0.060 |
Why?
| Immobilization | 1 | 2004 | 47 | 0.060 |
Why?
| Algorithms | 2 | 2023 | 1541 | 0.060 |
Why?
| Treatment Outcome | 4 | 2022 | 9342 | 0.060 |
Why?
| Neoplasms | 1 | 2018 | 2179 | 0.060 |
Why?
| Shoulder Dislocation | 1 | 2004 | 56 | 0.060 |
Why?
| Palivizumab | 1 | 2023 | 13 | 0.060 |
Why?
| Acromion | 1 | 2003 | 8 | 0.060 |
Why?
| State Medicine | 1 | 2022 | 21 | 0.060 |
Why?
| Arthroplasty | 1 | 2003 | 52 | 0.060 |
Why?
| Health Services | 1 | 2023 | 110 | 0.050 |
Why?
| Sensitivity and Specificity | 2 | 2023 | 1795 | 0.050 |
Why?
| Postoperative Complications | 1 | 2012 | 2235 | 0.050 |
Why?
| Psychiatric Nursing | 1 | 2001 | 6 | 0.050 |
Why?
| Dissociative Disorders | 1 | 2001 | 22 | 0.050 |
Why?
| Cadaver | 2 | 2004 | 327 | 0.050 |
Why?
| Vaccines, Inactivated | 1 | 2021 | 68 | 0.050 |
Why?
| Nurse-Patient Relations | 1 | 2001 | 46 | 0.050 |
Why?
| Vaccines, Attenuated | 1 | 2021 | 114 | 0.050 |
Why?
| Hip Prosthesis | 1 | 2000 | 33 | 0.050 |
Why?
| Transcription Factors | 1 | 2008 | 1570 | 0.050 |
Why?
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 49 | 0.050 |
Why?
| Social Networking | 1 | 2020 | 33 | 0.040 |
Why?
| Multicenter Studies as Topic | 1 | 2020 | 253 | 0.040 |
Why?
| Maternal Age | 1 | 2019 | 122 | 0.040 |
Why?
| Knee Joint | 1 | 2022 | 353 | 0.040 |
Why?
| Nursing Staff, Hospital | 1 | 2001 | 123 | 0.040 |
Why?
| Animals | 2 | 2013 | 33381 | 0.040 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2023 | 667 | 0.040 |
Why?
| Ultrasonography | 1 | 2003 | 716 | 0.040 |
Why?
| Serogroup | 1 | 2018 | 34 | 0.040 |
Why?
| Pharmacists | 1 | 2021 | 238 | 0.040 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2018 | 61 | 0.040 |
Why?
| Awareness | 1 | 2018 | 93 | 0.040 |
Why?
| Databases, Factual | 1 | 2023 | 1231 | 0.040 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2017 | 25 | 0.040 |
Why?
| Educational Status | 1 | 2019 | 437 | 0.040 |
Why?
| Accessory Nerve | 1 | 1997 | 3 | 0.040 |
Why?
| Risk Assessment | 3 | 2015 | 3057 | 0.040 |
Why?
| Patients | 1 | 2018 | 175 | 0.040 |
Why?
| Nurse Practitioners | 1 | 2018 | 107 | 0.040 |
Why?
| Interviews as Topic | 1 | 2019 | 599 | 0.040 |
Why?
| Health Plan Implementation | 1 | 2018 | 133 | 0.040 |
Why?
| Costs and Cost Analysis | 1 | 2017 | 202 | 0.040 |
Why?
| Insurance Coverage | 1 | 2018 | 208 | 0.040 |
Why?
| Self Report | 1 | 2020 | 699 | 0.030 |
Why?
| Pilot Projects | 1 | 2020 | 1419 | 0.030 |
Why?
| Patient Satisfaction | 1 | 2019 | 610 | 0.030 |
Why?
| Analysis of Variance | 1 | 2018 | 1293 | 0.030 |
Why?
| Models, Theoretical | 1 | 2019 | 556 | 0.030 |
Why?
| Treatment Failure | 1 | 2016 | 341 | 0.030 |
Why?
| Decision Support Techniques | 1 | 2018 | 364 | 0.030 |
Why?
| Ergonomics | 1 | 2014 | 23 | 0.030 |
Why?
| Wound Infection | 1 | 2014 | 31 | 0.030 |
Why?
| Prescriptions | 1 | 2014 | 63 | 0.030 |
Why?
| Efficiency | 1 | 2014 | 89 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2021 | 2513 | 0.030 |
Why?
| Sex Factors | 1 | 2019 | 1781 | 0.030 |
Why?
| Occupational Injuries | 1 | 2014 | 50 | 0.030 |
Why?
| Abscess | 1 | 2014 | 75 | 0.030 |
Why?
| Program Evaluation | 1 | 2018 | 845 | 0.030 |
Why?
| Medically Uninsured | 1 | 2014 | 125 | 0.030 |
Why?
| Interdisciplinary Communication | 1 | 2014 | 191 | 0.030 |
Why?
| Mice | 1 | 2008 | 15520 | 0.030 |
Why?
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 11 | 0.020 |
Why?
| Pharmaceutical Services | 1 | 2011 | 79 | 0.020 |
Why?
| Acute Disease | 2 | 2004 | 940 | 0.020 |
Why?
| Biomechanical Phenomena | 2 | 2004 | 683 | 0.020 |
Why?
| Referral and Consultation | 1 | 2014 | 648 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2014 | 2674 | 0.020 |
Why?
| Orthopedic Procedures | 1 | 2008 | 225 | 0.020 |
Why?
| Palliative Care | 1 | 2011 | 629 | 0.020 |
Why?
| Rotation | 1 | 2004 | 121 | 0.020 |
Why?
| Exercise | 1 | 2014 | 1657 | 0.020 |
Why?
| Posture | 1 | 2004 | 158 | 0.010 |
Why?
| Case-Control Studies | 1 | 2010 | 3171 | 0.010 |
Why?
| Range of Motion, Articular | 1 | 2004 | 369 | 0.010 |
Why?
| Machiavellianism | 1 | 2001 | 2 | 0.010 |
Why?
| Helping Behavior | 1 | 2001 | 15 | 0.010 |
Why?
| Nursing Methodology Research | 1 | 2001 | 44 | 0.010 |
Why?
| Chromium Alloys | 1 | 2000 | 5 | 0.010 |
Why?
| Durapatite | 1 | 2000 | 33 | 0.010 |
Why?
| Psychological Theory | 1 | 2001 | 96 | 0.010 |
Why?
| Porosity | 1 | 2000 | 93 | 0.010 |
Why?
| Bone Cements | 1 | 2000 | 39 | 0.010 |
Why?
| Coated Materials, Biocompatible | 1 | 2000 | 58 | 0.010 |
Why?
| Arthroplasty, Replacement, Hip | 1 | 2000 | 111 | 0.010 |
Why?
| Prosthesis Design | 1 | 2000 | 285 | 0.010 |
Why?
| Reoperation | 1 | 2000 | 557 | 0.010 |
Why?
| Social Support | 1 | 2001 | 542 | 0.010 |
Why?
| Survival Analysis | 1 | 2000 | 1267 | 0.010 |
Why?
|
|
O'Leary's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|